Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-23-000010
Filing Date
2023-05-08
Accepted
2023-05-08 08:33:08
Documents
82
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20230331x10q.htm   iXBRL 10-Q 1916117
2 EX-31.1 anip-20230331xex31d1.htm EX-31.1 11352
3 EX-31.2 anip-20230331xex31d2.htm EX-31.2 10772
4 EX-32.1 anip-20230331xex32d1.htm EX-32.1 8602
  Complete submission text file 0001023024-23-000010.txt   8639219

Data Files

Seq Description Document Type Size
5 EX-101.SCH anip-20230331.xsd EX-101.SCH 51459
6 EX-101.CAL anip-20230331_cal.xml EX-101.CAL 61747
7 EX-101.DEF anip-20230331_def.xml EX-101.DEF 275570
8 EX-101.LAB anip-20230331_lab.xml EX-101.LAB 418010
9 EX-101.PRE anip-20230331_pre.xml EX-101.PRE 427453
76 EXTRACTED XBRL INSTANCE DOCUMENT anip-20230331x10q_htm.xml XML 1624048
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 23895976
SIC: 2834 Pharmaceutical Preparations